<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-496
Date of Submission: 2025-05-05

This report was submitted by a Physician from Gordon, Luna and Barrett Medical Center concerning patient ANON-PX-2273. The subject is a 53-year-old other with a significant medical history including migraines, seasonal allergies. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Atorvastatin (Statin) administered via the Oral route at a dosage of 160mg, initiated on 2025-02-20 for Hypercholesterolemia and discontinued on 2025-04-15.

On approximately 2025-03-17, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Stevens-Johnson syndrome, Anaphylaxis, Diarrhea, Vomiting. The Stevens-Johnson syndrome was classified as Mild in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Unknown'. The Anaphylaxis was classified as Severe in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Fatal'. The Diarrhea was classified as Moderate in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Fatal'. The Vomiting was classified as Life-threatening in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovering'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Not applicable'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Small fast civil president shake course good. Process peace determine realize fly.</data>
report_id: ADR-2025-496
report_date: '2025-05-05'
patient_details:
  patient_id: ANON-PX-2273
  gender: Other
  relevant_history:
  - migraines
  - seasonal allergies
  age_at_reaction: 53
suspected_drugs:
- drug_name: Atorvastatin
  dosage: 160mg
  route_of_administration: Oral
  start_date: '2025-02-20'
  indication_for_use: Hypercholesterolemia
  drug_class: Statin
  end_date: '2025-04-15'
adverse_reactions:
- symptom_name: Stevens-Johnson syndrome
  onset_date: '2025-03-17'
  severity: Mild
  outcome: Unknown
  intervention_required: false
- symptom_name: Anaphylaxis
  onset_date: '2025-03-17'
  severity: Severe
  outcome: Fatal
  intervention_required: false
- symptom_name: Diarrhea
  onset_date: '2025-03-17'
  severity: Moderate
  outcome: Fatal
  intervention_required: false
- symptom_name: Vomiting
  onset_date: '2025-03-17'
  severity: Life-threatening
  outcome: Recovering
  intervention_required: false
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Not applicable
reporting_facility: Gordon, Luna and Barrett Medical Center
reporter_type: Physician
notes: Small fast civil president shake course good. Process peace determine realize
  fly.
